Aurobindo Pharm's December 2025 Standalone Net Sales Decline 5.81% to Rs 2,747.28 Crore

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

M

Moneycontrol•10-02-2026, 12:33

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

•Aurobindo Pharma reported standalone net sales of Rs 2,747.28 crore in December 2025, a 5.81% decrease year-on-year.
•Quarterly Net Profit surged by 23.31% to Rs 582.07 crore in December 2025, up from Rs 472.05 crore in December 2024.
•EBITDA increased by 19.84% to Rs 919.63 crore in December 2025.
•Earnings Per Share (EPS) rose to Rs 10.02 in December 2025 from Rs 8.13 in December 2024.
•Aurobindo Pharm shares delivered 14.32% returns over the last 6 months and 2.26% over the last 12 months.

Read Full Article on Moneycontrol in English

✦

More like this

✦

More like this

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

Aurionpro Solutions: Net Sales Up, Profit Down in Dec 2025 Quarter

Aurionpro Solutions: Net Sales Up, Profit Down in Dec 2025 Quarter

Aurobindo Pharma Q3 Profit Jumps 7% to Rs 910 Cr, Revenue Up 8%

Aurobindo Pharma Q3 Profit Jumps 7% to Rs 910 Cr, Revenue Up 8%

Bharti Hexacom's Net Sales Up 4.85%, Net Profit Soars 81.56% in Dec 2025 Quarter

Bharti Hexacom's Net Sales Up 4.85%, Net Profit Soars 81.56% in Dec 2025 Quarter

Representational image (Image: News18)

Aurobindo Pharma Q3 Profit Jumps 8% to Rs 910 Cr on Strong Sales

PVR INOX Q3 2025: Net Sales Up 11.14%, Profit Soars 175.36% Y-o-Y

PVR INOX Q3 2025: Net Sales Up 11.14%, Profit Soars 175.36% Y-o-Y